Synfacts, Table of Contents Synfacts 2022; 18(09): 1032DOI: 10.1055/s-0041-1738302 Innovative Drug Discovery and Development Design and Synthesis of NTQ1062, a new Akt Inhibitor Clinical CandidateContributor(s): Antonia F. Stepan (Roche) , Nadine Kuhl (Merck Sharp & Dohme)Recommend Article Abstract Buy ArticleKey words Key wordsstructure–activity relationship - ATP competitive Akt inhibitors - cancer therapy - antitumor drugs - enzyme inhibitors Full Text